Invention Grant
- Patent Title: Anti-AREG/HB-EGF antibodies and treatment
- Patent Title (中): 抗AREG / HB-EGF抗体和治疗
-
Application No.: US12988135Application Date: 2009-04-17
-
Publication No.: US08846868B2Publication Date: 2014-09-30
- Inventor: Jill Caswell , Shane Olwill , James Johnston , Richard Buick , Thomas Jaquin , Declan Doherty , Christopher Scott
- Applicant: Jill Caswell , Shane Olwill , James Johnston , Richard Buick , Thomas Jaquin , Declan Doherty , Christopher Scott
- Applicant Address: GB Belfast
- Assignee: Fusion Antibodies Limited
- Current Assignee: Fusion Antibodies Limited
- Current Assignee Address: GB Belfast
- Agency: Drinker, Biddle & Reath, LLP
- Priority: GB0807018.7 20080417
- International Application: PCT/GB2009/050389 WO 20090417
- International Announcement: WO2009/127881 WO 20091022
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12P21/08 ; C07K16/22 ; A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
Described are cross-specific antibody molecules with binding specificity for both AREG and HBEGF. The antibody molecules may be used in methods of treatment of cancer and diseases associated with angiogenesis.
Public/Granted literature
- US20110150886A1 ANTI-AREG/HB-EGF ANTIBODIES AND TREATMENT Public/Granted day:2011-06-23
Information query
